CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Denosumab

Last Updated: August 26, 2010
Result type: Reports
Project Number: S0208
Product Line: Common Drug Review

Generic Name: Denosumab

Brand Name: Prolia

Manufacturer: Amgen Canada Inc.

Indications: Osteoporosis, postmenopausal women

Submission Type: New

Project Status: Complete

Date Recommendation Issued: March 30, 2011

Recommendation Type: List with clinical criteria and/or conditions